# Virtual Incision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virtual-incision

- Industry: Medical Devices & Equipment
- Headquarters: Lincoln, US
- Website: www.virtualincision.com
- Total disclosed funding: $114M
- Latest round: Series C (Sep 19, 2023)
- Investors on record: 8

## About

Virtual Incision Corporation, based in the US, specializes in developing innovative robotic-assisted surgical technologies aimed at improving surgical precision while minimizing patient recovery times.Founded in 2006 and headquartered in Lincoln, US, Virtual Incision Corporation focuses on providing advanced solutions in robotic-assisted surgery. The company has raised a total of USD 22.53 mn in funding, including its latest Series C round on September 19, 2023, co-led by notable investors such as Baird Capital Partners and Bluestem Capital Company. The founder's specific history is not disclosed, but the company’s journey has been marked by strategic focus on miniaturized surgical technologies.Virtual Incision's primary offering is the MIRA Surgical System, a pioneering miniaturized robotic-assisted surgery platform designed to enhance surgical precision through minimally invasive techniques. This system enables surgeries to be performed through small incisions, contributing to reduced hospital stays and lower complication rates. The MIRA system aims to address accessibility challenges in traditional robotic surgery, allowing healthcare facilities to incorporate this technology within their existing infrastructure, thereby serving hospitals, surgical centers, and healthcare providers across the US and expanding international markets.Virtual Incision generates revenue primarily through the sale of its MIRA Surgical System to healthcare providers, which involve direct sales agreements for capital investment in surgical departments. The company also provides ongoing support services, training, and maintenance agreements, focusing on enhancing surgical outcomes for patients and efficiency for providers.In September 2023, Virtual Incision Corporation raised USD 22.53 mn in Series C funding to support its operations. The company aims to expand its market presence and enhance the capabilities of its MIRA Surgical System. Specific plans for new product developments and market expansions have not been disclosed, but the recent funding will bolster its operational framework to facilitate growth and development in the healthcare sector.

## Funding rounds

- Series C, Sep 19, 2023, $23M — Bluestem Capital Company, Baird Capital Partners, Arboretum Ventures, Endeavour Vision, PrairieGold Venture Partners, InVivium Capital
- Series C, Nov 29, 2021, $43M — Bluestem Capital Company, Baird Capital Partners, Endeavour Vision
- Series B, Jan 8, 2020, $20M — Bluestem Capital Company, PrairieGold Venture Partners, Genesis Innovation Group
- Series B, Oct 15, 2019, $10M — Bluestem Capital Company
- Series B, Dec 1, 2017, $15M — Bluestem Capital Company, PrairieGold Venture Partners, Shanghai Jianyi Private Equity Fund Management
- Series A, Jun 30, 2015, $1.8M — Bluestem Capital Company, PrairieGold Venture Partners
- Series A, Oct 28, 2010, $1.8M — Bluestem Capital Company, PrairieGold Venture Partners

## Investors

- Bluestem Capital Company (https://capitalatlas.ai/funds/bluestem-capital-company) — Series A, Series B, Series C
- PrairieGold Venture Partners (https://capitalatlas.ai/funds/prairiegold-venture-partners) — Series A, Series B, Series C
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series B
- Genesis Innovation Group (https://capitalatlas.ai/funds/genesis-innovation-group) — Series B
- Baird Capital Partners (https://capitalatlas.ai/funds/baird-capital-partners) — Series C
- Endeavour Vision (https://capitalatlas.ai/funds/endeavour-vision) — Series C
- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series C
- InVivium Capital (https://capitalatlas.ai/funds/invivium-capital) — Series C